Ceapro Short Interest Ratio and Short Volume

Short interest is the volume of Ceapro shares that have been sold short but have not yet been covered or closed out. As of December 31st, traders have sold 200 shares of CRPOF short. 0.00% of Ceapro's shares are currently sold short. View details.

Ceapro saw a decline in short interest in December. As of December 31st, there was short interest totaling 200 shares, a decline of 97.8% from the previous total of 8,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.00% of Ceapro's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Ceapro: Eyenovia, Inc. (0.32%), Corbus Pharmaceuticals Holdings, Inc. (0.00%), Genprex, Inc. (0.00%), Enlivex Therapeutics Ltd. (3.54%), Orgenesis Inc. (0.00%), Enochian Biosciences, Inc. (6.45%), Capricor Therapeutics Inc (0.00%), vTv Therapeutics Inc. (29.40%), Leap Therapeutics, Inc. (0.00%), and Adamis Pharmaceuticals Co. (0.00%).

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($5.18 billion), ViacomCBS Inc. ($4.71 billion), Analog Devices, Inc. ($4.45 billion), Aon Plc ($4.28 billion), Snap Inc. ($3.70 billion), Moderna, Inc. ($3.00 billion), The Clorox Company ($2.46 billion), Peloton Interactive, Inc. ($2.40 billion), The Kroger Co. ($2.38 billion), and Expedia Group, Inc. ($2.37 billion). View all of the most shorted stocks.

Short selling CRPOF is an investing strategy that aims to generate trading profit from Ceapro as its price is falling. Ceapro's stock is trading up $0.02 today. To short Ceapro stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Ceapro will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Ceapro occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CRPOF, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRPOF, twice per month. The most recent reporting period available is December, 31 2020.